March 17, 2021
Article
The new findings support increased protection from reinfection up to 6 months after first testing positive, though older patients are at greater risk of reinfection.
Researchers and clinicians continually failed to connect with the greater public on matters of the pandemic. What drove the divide between the already distanced groups?
March 15, 2021
A comparative study of same-day and seven-day TB test results show there is little difference in HIV treatment adherence or outcomes at 48 weeks.
March 12, 2021
The data additionally show a 94% prevention against asymptomatic SARS-CoV-2 infection, at a time when the country's dominant strain was the B.1.1.7 variant.
Though the product is authorized more than 70 countries, there is currently no reported US trial data, nor application for authorization to the FDA.
March 11, 2021
Macrolide-resistant strains of Streptococcus pneumoniae account for almost 40% of infections overall, a new study found.
March 10, 2021
While at the earliest stages of potential development, long-acting/extended release (LA/ER) formulations for treatment and prevention of TB could be something to be studied in the future.
March 09, 2021
Johns Hopkins data suggest men are being hospitalized more frequently with infection, and are facing more severe outcomes.
A UK health authority representative discussed the possibility of a fall season booster to prevent another winter surge of cases.
March 08, 2021
Though small in scale and still cautious, the new advisory reflects confidence in SARS-CoV-2 mitigation among a more vaccinated population.
